These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 27233303

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
    Alexandre EC, Leiria LO, Silva FH, Mendes-Silvério CB, Calmasini FB, Davel AP, Mónica FZ, De Nucci G, Antunes E.
    J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
    Bice JS, Keim Y, Stasch JP, Baxter GF.
    Cardiovasc Res; 2014 Feb 01; 101(2):220-8. PubMed ID: 24259501
    [Abstract] [Full Text] [Related]

  • 9. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
    Wang WZ, Jones AW, Wang M, Durante W, Korthuis RJ.
    Am J Physiol Heart Circ Physiol; 2013 Aug 15; 305(4):H521-32. PubMed ID: 23771693
    [Abstract] [Full Text] [Related]

  • 10. Soluble guanylate cyclase redox state under hypoxia or hypoxia/reoxygenation in isolated monkey coronary arteries.
    Tawa M, Geddawy A, Shimosato T, Iwasaki H, Imamura T, Okamura T.
    J Pharmacol Sci; 2014 Aug 15; 125(2):169-75. PubMed ID: 24859780
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
    Ghosh A, Stasch JP, Papapetropoulos A, Stuehr DJ.
    J Biol Chem; 2014 May 30; 289(22):15259-71. PubMed ID: 24733395
    [Abstract] [Full Text] [Related]

  • 12. Preserved activity of soluble guanylate cyclase (sGC) in iliac artery from middle-aged rats: Role of sGC modulators.
    Justo AFO, de Oliveira MG, Calmasini FB, Alexandre EC, Bertollotto GM, Jacintho FF, Antunes E, Mónica FZ.
    Nitric Oxide; 2021 Jan 01; 106():9-16. PubMed ID: 33122152
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum.
    Estancial CS, Rodrigues RL, De Nucci G, Antunes E, Mónica FZ.
    BJU Int; 2015 Oct 01; 116(4):657-64. PubMed ID: 25715977
    [Abstract] [Full Text] [Related]

  • 14. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
    Mendes-Silverio CB, Leiria LO, Morganti RP, Anhê GF, Marcondes S, Mónica FZ, De Nucci G, Antunes E.
    PLoS One; 2012 Oct 01; 7(11):e47223. PubMed ID: 23144808
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G, Burnett JC.
    Cardiovasc Drug Rev; 2007 Oct 01; 25(1):30-45. PubMed ID: 17445086
    [Abstract] [Full Text] [Related]

  • 16. Responsiveness of rat aorta and pulmonary artery to cGMP generators in the presence of thiol or heme oxidant.
    Tawa M, Yamashita Y, Masuoka T, Nakano K, Yoshida J, Nishio M, Ishibashi T.
    J Pharmacol Sci; 2019 May 01; 140(1):43-47. PubMed ID: 31036520
    [Abstract] [Full Text] [Related]

  • 17. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
    Tsai EJ, Liu Y, Koitabashi N, Bedja D, Danner T, Jasmin JF, Lisanti MP, Friebe A, Takimoto E, Kass DA.
    Circ Res; 2012 Jan 20; 110(2):295-303. PubMed ID: 22095726
    [Abstract] [Full Text] [Related]

  • 18. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
    Silva FH, Leiria LO, Alexandre EC, Davel AP, Mónica FZ, De Nucci G, Antunes E.
    J Sex Med; 2014 Nov 20; 11(11):2661-70. PubMed ID: 25196910
    [Abstract] [Full Text] [Related]

  • 19. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS, Schmidt PM, Keim Y, Schaefer S, Schmidt HH, Stasch JP.
    Br J Pharmacol; 2009 Jul 20; 157(5):781-95. PubMed ID: 19466990
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
    Knorr A, Hirth-Dietrich C, Alonso-Alija C, Härter M, Hahn M, Keim Y, Wunder F, Stasch JP.
    Arzneimittelforschung; 2008 Jul 20; 58(2):71-80. PubMed ID: 18412020
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.